Abstract
The aim of this paper is to review the inhibitors of apoptosis proteins, a recently discovered group of caspase inhibitors. We will briefly review the relevance of apoptosis in prostate cancer and some of the control mechanisms, before describing the structure, function and regulation of these molecules. Lastly, we will consider the evidence for the role that IAPs may have in cancer and the implications for prostate cancer in particular.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 4 print issues and online access
$259.00 per year
only $64.75 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
McEleny, K., Watson, R. & Fitzpatrick, J. Defining a role for the inhibitors of apoptosis proteins in prostate cancer. Prostate Cancer Prostatic Dis 4, 28–32 (2001). https://doi.org/10.1038/sj.pcan.4500502
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.pcan.4500502
Keywords
This article is cited by
-
Functional promoter -31G/C variant of Survivin gene predict prostate cancer susceptibility among Chinese: a case control study
BMC Cancer (2013)
-
The role of the mitochondria in mediating cytotoxicity of anti-cancer therapies
Journal of Bioenergetics and Biomembranes (2007)
-
Mechanisms of resistance to TRAIL-induced apoptosis in cancer
Cancer Gene Therapy (2005)